Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsGraft vs Host DiseaseBusulfanTreatment OutcomeGraft SurvivalLymphoma, Non-HodgkinBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHematopoiesisHodgkin DiseaseCord Blood Stem Cell TransplantationDisease-Free SurvivalTissue DonorsTransplantation ChimeraRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsInfectionSurvival AnalysisLymphoma, T-CellHistocompatibilityDoxorubicinImmunosuppressive AgentsPOEMS SyndromePlatelet CountHistocompatibility TestingPrednisoneCarboplatinTransplantation, IsogeneicLeukemia, Myeloid, AcuteDexamethasoneVidarabineFollow-Up StudiesBlood Cell CountRecombinant ProteinsLeukemiaCytomegalovirus InfectionsBone Marrow PurgingAntineoplastic AgentsProspective StudiesLymphomaBlood CellsFatal OutcomeGraft vs Leukemia EffectFeasibility StudiesKidney TransplantationMyelodysplastic SyndromesAnemia, AplasticImmunophenotypingBlood Transfusion, AutologousLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionLiver TransplantationCyclosporineOpportunistic InfectionsT-LymphocytesLeukocytes, MononuclearImmunosuppressionHLA AntigensHematologic DiseasesHistiocytosis, Non-Langerhans-CellLivedo ReticularisPrecursor Cell Lymphoblastic Leukemia-LymphomaPrognosisBone MarrowBlood DonorsBreast NeoplasmsMesenchymal Stem Cell Transplantation